Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paxlovid in Hemodialysis Patients With SARS-CoV-2 Infection
NCT05366192Phase 4Completed
- Sponsor
- Renji Hospital
- Start
- May 2022
- Primary completion
- Jun 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of Nirmatrelvir in coronavirus disease 2019 (COVID-19), sponsored by Renji Hospital. Started May 2022; status: completed.
02
Drugs
Nirmatrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05366192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05366192.